Eva Petkova

Eva Petkova

Auto-generated profile, based on publicly available information

Eva Petkova

Department of Population Health, Grossman School of Medicine, New York University, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2009 in Journal of Traumatic Stress
Verified
Journal Article
Closed access
PDF file
MCMarylene Cloitre
Marylene Cloitre
BSBradley C. Stolbach
Bradley C. Stolbach
JHJudith L. Herman
Judith L. Herman
BKBessel van der Kolk
Bessel van der Kolk
RPRobert Pynoos
Robert Pynoos
EPEva Petkova
Eva Petkova

16 February 2009 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
ZSZarrar Shehzad
Zarrar Shehzad
AKA. M. Clare Kelly
A. M. Clare Kelly
PRPhilip T. Reiss
Philip T. Reiss
DGDylan G. Gee
Dylan G. Gee
KGKristin Gotimer
Kristin Gotimer
MMMichael P. Milham
Michael P. Milham
Recent years have witnessed an upsurge in the usage of resting-state functional magnetic resonance imaging (fMRI) to examine functional connectivity (fcMRI), both in normal and pathological populations. Despite this increasing popularity, concerns about the psychologically unconstrained nature of the “resting-state” remain. Across studies, the patterns of functional connectivity detected are remarkably consistent. However, the test–retest reliability for measures of resting state fcMRI measures has not been determined. Here, we quantify the test–retest reliability, using resting scans from 26 participants at 3 different time points. Specifically, we assessed intersession (>5 months apart), intrasession ( nonsignificant), 2) correlation valence (positive > negative), and 3) network membership (default mode > task positive network). Short- and long-term measures of the consistency of global connectivity patterns were highly robust. Finally, hierarchical clustering solutions were highly reproducible, both across participants and sessions. Our findings provide a solid foundation for continued examination of resting state fcMRI in typical and atypical populations.

1 January 2012 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
KNKate Brody Nooner
Kate Brody Nooner
SCStanley J. Colcombe
Stanley J. Colcombe
RTRussell H. Tobe
Russell H. Tobe
MMMaarten Mennes
Maarten Mennes
MBMelissa M. Benedict
Melissa M. Benedict
MMMichael P. Milham
Michael P. Milham
The National Institute of Mental Health strategic plan for advancing psychiatric neuroscience calls for an acceleration of discovery and the delineation of developmental trajectories for risk and resilience across the lifespan. To attain these objectives, sufficiently powered datasets with broad and deep phenotypic characterization, state-of-the-art neuroimaging, and genetic samples must be generated and made openly available to the scientific community. The enhanced Nathan Kline Institute-Rockland Sample (NKI-RS) is a response to this need. NKI-RS is an ongoing, institutionally centered endeavor aimed at creating a large-scale (N > 1000), deeply phenotyped, community-ascertained, lifespan sample (ages 6–85 years old) with advanced neuroimaging and genetics. These data will be publically shared, openly, and prospectively (i.e., on a weekly basis). Herein, we describe the conceptual basis of the NKI-RS, including study design, sampling considerations, and steps to synchronize phenotypic and neuroimaging assessment. Additionally, we describe our process for sharing the data with the scientific community while protecting participant confidentiality, maintaining an adequate database, and certifying data integrity. The pilot phase of the NKI-RS, including challenges in recruiting, characterizing, imaging, and sharing data, is discussed while also explaining how this experience informed the final design of the enhanced NKI-RS. It is our hope that familiarity with the conceptual underpinnings of the enhanced NKI-RS will facilitate harmonization with future data collection efforts aimed at advancing psychiatric neuroscience and nosology.

1 August 2010 in American Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
MCMarylene Cloitre
Marylene Cloitre
KSK. Chase Stovall-McClough
K. Chase Stovall-McClough
KNKate Nooner
Kate Nooner
PZPatty Zorbas
Patty Zorbas
SCStephanie Cherry
Stephanie Cherry
EPEva Petkova
Eva Petkova

1 March 2012 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
CLCatherine Lord
Catherine Lord
EPEva Petkova
Eva Petkova
VHVanessa Hus
Vanessa Hus
WGWeijin Gan
Weijin Gan
FLFeihan Lu
Feihan Lu
SRSusan Risi
Susan Risi
In the field of autism spectrum disorders (ASDs), diagnostic instruments have been helpful in defining populations,1 merging samples,2 and comparing results across studies.3,4 Nevertheless, best-estimate clinical (BEC) diagnoses have long been the gold standard.5-7 In single-site studies, BEC diagnoses have added information to standardized instruments to predict later diagnoses8,9 and classify children according to developmental trajectories of adaptive and language functioning.10,11 However, researchers have recently expressed skepticism about the scientific and clinical value of categorical ASD groupings in the DSM-IV-TR12 and the International Statistical Classification of Diseases, 10th Revision13 (ie, autistic disorder, pervasive developmental disorder–not otherwise specified [PDD-NOS], Asperger syndrome), on which BEC diagnoses are based.5,14,15

1 July 2016 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
MTMadhukar Trivedi
Madhukar Trivedi
PMPatrick J. McGrath
Patrick J. McGrath
MFMaurizio Fava
Maurizio Fava
RPRamin V. Parsey
Ramin V. Parsey
BKBenji T. Kurian
Benji T. Kurian
MWMyrna M. Weissman
Myrna M. Weissman